Experts Look At The Meaning Of Myriad Case, One Year Later

Cal Irvine law school myriad conf Sept 2014

IRVINE, CALIFORNIA – Experts gathered here last week addressed the question of – one year later – what does the United States Supreme Court’s decision on human gene patents mean for scientific research and patent policy?

Guest Post: Nine Mandatory Licences Allow Greater Access To Medicines In Ecuador

Health 1

What is a mandatory licence? Mandatory licenses are a legal remedy within the intellectual property flexibilities provided by the World Trade Organization allowing a government to grant permission to third parties to produce a patented product or use a patented process without the consent of the patentee, in order to address a priority status for the country.

Flexible IPR Approach For European Joint Innovation Projects

EU Flag

Applicants to the European “Innovation Communities” initiative have until 10 September to submit joint innovation proposals in the areas of healthy aging and raw materials. The aim is to create new organisations compliant with the European grant programme Horizon 2020, which will operate under flexible intellectual property rights’ policies in collaborative innovation projects.

WHO: Fight Ebola Now, Solve Patent Issues Later

WHO Ebola Briefing - Sept 2014

The world and the global health community have been taken by surprise by the worst outbreak of Ebola so far. The World Health Organization today (5 September) said a vaccine could be available in November 2014 if proven safe. So far, according to the WHO, intellectual property issues have not acted as a barrier to accessing potential treatments and vaccines, and the focus for now is on emergency measures to find health solutions.

India’s IP Policy On Stage As Modi Heads To US

Pills-Flickr-Taki-Steve

Will India’s new government bring in radical changes in the country’s intellectual property rights regime? That question has generated enormous buzz but no definitive answer ever since the Bharatiya Janata Party (BJP) swept to power with a decisive mandate in May this year.

[Update: the Indian government has announced that it has begun a process for a comprehensive IPR policy over the next six months, including a government think tank. See report here. The government website is here.]

Biosimilar Medicines Need Strong Regulation, IP Crucial For Innovation, Pharma Says

Biosimilar medicines might prove to be a new reservoir for innovation for the pharmaceutical industry. However, the complexity of their manufacture needs a stringent regulatory framework, according to the industry.

WHO Raises Its Voice To Underline Health Effects Of Climate Change

The World Health Organization this week is holding its first conference on health and climate change. The major objective of the conference is to raise awareness on the impact of climate change on health, according to the WHO, which said it aims to strengthen its voice in the debate.

Médecins Sans Frontières Warns About IP Inclusion In Asian FTA

The inclusion of intellectual property in the ongoing negotiations of the Regional Comprehensive Economic Partnership between 16 countries, most of them Asian, is raising concerns about “TRIPS-plus” measures that could jeopardise generic drugs production in India, according to Médecins Sans Frontières.

Market Failure, Not IP, The Issue In Ebola Treatment Shortage, WHO Says

Faced with the worst outbreak of Ebola since its discovery some 40 years ago, the world is scrambling for treatments. A World Health Organization-convened panel of experts has decided it is ethical to use experimental treatments. Why is there no treatment available even after 40 years? Market failure, not intellectual property rights, says the WHO.